+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Atrial Fibrillation: Technologies and Global Markets

  • ID: 4662608
  • Report
  • October 2018
  • Region: Global
  • 120 pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Aegis Medical Innovations
  • Biotronik
  • Cathrx
  • Kardium
  • Medtronic
  • MORE

Report Scope:

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

Devices included as a part of market estimates are:

  • Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables.
  • Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.

Devices excluded from market estimates are:

  • Pharmacological drugs employed in standalone and combination of ablation procedures.
  • Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors).
  • ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices.
  • Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices.
  • Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.

The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

The Report Includes:

  • 25 data tables and 13 additional tables
  • An overview of the global market for atrial fibrillation and technologies
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
  • Discussion of the types of atrial fibrillation treatment
  • A look into various government regulations
  • Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
  • Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Aegis Medical Innovations
  • Biotronik
  • Cathrx
  • Kardium
  • Medtronic
  • MORE
Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports
Chapter 2 Summary and Highlights

Chapter 3 Background
  • Heart Structure and Function
  • Cardiac Arrhythmia
  • Treadmill Run Test Stress Test
  • Holter Monitoring
  • Echocardiography
  • Electrophysiologic Testing
  • Atrial Fibrillation (AFib)
  • Symptoms
  • Global Epidemiology
  • Economic Burden of Atrial Fibrillation
  • Risk Factors
  • Complications of Atrial Fibrillation
  • Patterns of Atrial Fibrillation
  • Current Standard of Care for Atrial Fibrillation
  • Diagnosis
  • Treatment of AFib
Chapter 4 Market Overview
  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Emerging Trends
  • Regulatory Landscape
  • Regulation in Europe
  • Regulation in the U.S.
  • Regulation in Japan
  • Regulation in China
  • Regulation in India
Chapter 5 Market Breakdown by Device Type
  • Introduction and Global Markets
  • Catheter Ablation Devices
  • Overview
  • Market Size and Forecast
  • Catheter Ablation Devices by Type
  • Left Atrial Appendage (LAA) Closure Devices
  • Overview
  • Cost Benefits of Left Atrial Appendage Closure Devices vs. Pharmacological Therapy
  • Market Size and Forecast
  • Types of Left Atrial Appendage Implantation
Chapter 6 Market Breakdown by Region
  • Introduction
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of the World
Chapter 7 Competitive Landscape and Recent Developments
  • Market Share Analysis
  • Atrial Fibrillation: Company Market Share Analysis
  • Strategies Adopted by Market Leaders
  • Catheter Ablation Devices: Company Market Share Analysis
  • Left Atrial Appendage Closure Devices: Company Market Share Analysis
  • Barriers to the Entry for New Players
  • High Degree of Competitiveness
  • Product Portfolio Analysis
  • Catheter Ablation Devices Product Portfolio Analysis
  • Left Atrial Appendage Closure Devices Product Portfolio Analysis
  • Key Recent Industry Events
Chapter 8 Company Profiles
  • ABBOTT LABORATORIES
  • Company Overview
  • Financials
  • Atrial Fibrillation Business
  • Product Portfolio
  • Development and Strategies
  • ABLACOR MEDICAL CORP.
  • Company Overview
  • ACUTUS MEDICAL INC
  • Company Overview
  • AEGIS MEDICAL INNOVATIONS
  • Company Overview
  • AFREEZE GMBH
  • Company Overview
  • AURIS HEALTH (HANSEN MEDICAL)
  • Company Overview
  • ATRICURE INC
  • Company Overview
  • Financials
  • Business of Atrial Fibrillation
  • Product Portfolio
  • BIOTRONIK
  • Company Overview
  • BOSTON SCIENTIFIC
  • Company Overview
  • Financials
  • Product Portfolio
  • CARDIOFOCUS
  • Company Overview
  • CATHRX
  • Company Overview
  • GE HEALTHCARE
  • Company Overview
  • Financials
  • JOHNSON & JOHNSON
  • Company Overview
  • Financials
  • Business of Atrial Fibrillation
  • Product Portfolio
  • KARDIUM
  • Company Overview
  • LIFETECH SCIENTIFIC CORP.
  • Company Overview
  • LUXCATH
  • Company Overview
  • MEDTRONIC
  • Company Overview
  • Financials
  • Product Portfolio
  • MICROPORT SCIENTIFIC CORP.
  • Company Overview
  • Financials
  • PHILIPS HEALTHCARE
  • Company Overview
  • Financials
  • SENTREHEART
  • Company Overview
  • STEREOTAXIS
  • Company Overview
Chapter 9 Appendix: Acronyms
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Ablacor Medical Corp.
  • Acutus Medical Inc
  • Aegis Medical Innovations
  • Afreeze Gmbh
  • Atricure Inc
  • Auris Health (Hansen Medical)
  • Biotronik
  • Boston Scientific
  • Cardiofocus
  • Cathrx
  • Ge Healthcare
  • Johnson & Johnson
  • Kardium
  • Lifetech Scientific Corp.
  • Luxcath
  • Medtronic
  • Microport Scientific Corp.
  • Philips Healthcare
  • Sentreheart
  • Stereotaxis
Note: Product cover images may vary from those shown
Adroll
adroll